73.78
0.55%
+0.40
Merit Medical Systems, Inc. stock is currently priced at $73.78, with a 24-hour trading volume of 279.30K.
It has seen a +0.55% increased in the last 24 hours and a +1.19% rose in the past month.
The chart indicates a potential bullish trend, as the stock is above the $73.47 pivot point. If it approaches the $74.14 resistance level, significant changes may occur.
Previous Close:
$73.38
Open:
$73.4
24h Volume:
279.30K
Market Cap:
$4.28B
Revenue:
$1.26B
Net Income/Loss:
$94.41M
P/E Ratio:
42.65
EPS:
1.73
Net Cash Flow:
$108.45M
1W Performance:
+2.43%
1M Performance:
+1.19%
6M Performance:
+16.21%
1Y Performance:
-5.01%
Merit Medical Systems, Inc. Stock (MMSI) Company Profile
Name
Merit Medical Systems, Inc.
Sector
Industry
Phone
801-253-1600
Address
1600 West Merit Parkway, South Jordan, UT
Merit Medical Systems, Inc. Stock (MMSI) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Feb-07-24 | Initiated | BofA Securities | Neutral |
Dec-21-23 | Upgrade | Canaccord Genuity | Hold → Buy |
Dec-20-22 | Downgrade | Canaccord Genuity | Buy → Hold |
Jan-05-21 | Upgrade | Needham | Hold → Buy |
Sep-28-20 | Upgrade | Wells Fargo | Underweight → Equal Weight |
Feb-25-20 | Downgrade | Barrington Research | Outperform → Mkt Perform |
Feb-03-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
Dec-12-19 | Downgrade | Wells Fargo | Market Perform → Underperform |
Sep-24-19 | Initiated | Oppenheimer | Outperform |
Sep-10-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
Jul-26-19 | Downgrade | Needham | Buy → Hold |
Jul-26-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
Oct-02-18 | Reiterated | Needham | Buy |
Aug-07-18 | Downgrade | BofA/Merrill | Buy → Underperform |
Jul-24-18 | Reiterated | Needham | Buy |
Jun-01-18 | Reiterated | Needham | Buy |
May-18-18 | Reiterated | SunTrust | Buy |
Apr-26-18 | Reiterated | Needham | Buy |
Apr-20-18 | Initiated | Needham | Buy |
Mar-01-18 | Upgrade | Barrington Research | Mkt Perform → Outperform |
Aug-28-17 | Downgrade | Raymond James | Strong Buy → Outperform |
Jul-20-17 | Initiated | BofA/Merrill | Buy |
Jun-20-17 | Initiated | SunTrust | Buy |
Apr-05-17 | Initiated | Wells Fargo | Outperform |
View All
Merit Medical Systems, Inc. Stock (MMSI) Latest News
Cardinal Health (CAH) Reports Next Week: Wall Street Expects Earnings Growth
Zacks Investment Research
Merit Medical (MMSI) Earnings Expected to Grow: Should You Buy?
Zacks Investment Research
BDX or MMSI: Which Is the Better Value Stock Right Now?
Zacks Investment Research
Decoding 7 Analyst Evaluations For Merit Medical Systems
Benzinga
Here's Why You Should Retain Merit Medical (MMSI) Stock for Now
Zacks Investment Research
BDX vs. MMSI: Which Stock Is the Better Value Option?
Zacks Investment Research
Merit Medical Systems, Inc. Stock (MMSI) Financials Data
Merit Medical Systems, Inc. (MMSI) Revenue 2024
MMSI reported a revenue (TTM) of $1.26 billion for the quarter ending December 31, 2023, a +9.24% rise year-over-year.
Merit Medical Systems, Inc. (MMSI) Net Income 2024
MMSI net income (TTM) was $94.41 million for the quarter ending December 31, 2023, a +26.70% increase year-over-year.
Merit Medical Systems, Inc. (MMSI) Cash Flow 2024
MMSI recorded a free cash flow (TTM) of $108.45 million for the quarter ending December 31, 2023, a +64.10% increase year-over-year.
Merit Medical Systems, Inc. (MMSI) Earnings per Share 2024
MMSI earnings per share (TTM) was $1.63 for the quarter ending December 31, 2023, a +25.38% growth year-over-year.
Merit Medical Systems, Inc. Stock (MMSI) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Wright Joseph | CHIEF COMMERCIAL OFFICER |
Mar 07 '24 |
Option Exercise |
28.20 |
25,000 |
705,000 |
67,223 |
Wright Joseph | CHIEF COMMERCIAL OFFICER |
Mar 07 '24 |
Sale |
75.68 |
25,000 |
1,891,925 |
42,223 |
Peterson Neil | CHIEF OPERATING OFFICER |
Mar 06 '24 |
Option Exercise |
44.80 |
7,500 |
336,000 |
14,819 |
Gunderson Thomas James | Director |
Mar 04 '24 |
Option Exercise |
34.40 |
25,000 |
860,000 |
37,414 |
Gunderson Thomas James | Director |
Mar 04 '24 |
Sale |
76.03 |
18,157 |
1,380,513 |
19,257 |
Evans Stephen C. | Director |
Mar 04 '24 |
Sale |
76.35 |
1,000 |
76,348 |
7,226 |
Millner F. Ann | Director |
Jan 22 '24 |
Option Exercise |
34.40 |
20,000 |
688,000 |
49,960 |
Millner F. Ann | Director |
Jan 22 '24 |
Sale |
80.00 |
20,000 |
1,600,000 |
29,960 |
LAMPROPOULOS FRED P | PRESIDENT AND CEO |
Aug 25 '23 |
Option Exercise |
28.20 |
200,000 |
5,640,000 |
1,167,916 |
LAMPROPOULOS FRED P | PRESIDENT AND CEO |
Aug 25 '23 |
Option Exercise |
28.20 |
6,000 |
169,200 |
12,888 |
About Merit Medical Systems, Inc.
Merit Medical Systems, Inc. designs, develops, manufactures, and markets various disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates through Cardiovascular and Endoscopy segments. It provides various peripheral intervention products, including access, angiography, intervention, and drainage and biopsy products to alleviate patients suffering from peripheral vascular and non-vascular diseases; and cardiac intervention products to aid in the treatment of various cardiac conditions specific to interventional cardiology and electrophysiology, including cardiac rhythm management and lead management. The company also offers cardiovascular and critical care products comprising infection prevention and safety, and fluid management and monitoring devices. In addition, it provides interventional oncology and spine products, such as vertebral compression fractures; tumor ablation systems; inflation syringes; microspheres for treating hypervascularized tumors and liver cancer; polyvinyl alcohol particles to treat hypervascularized tumors; and microcatheters for the controlled and selective infusion of diagnostic, embolic, or therapeutic agents into vessels. Further, the company offers endoscopy products, such as non-vascular stents, esophageal stents, biliary stent systems, esophageal balloon dilators, inflation devices, and guide wires; and kits and accessories for endoscopy and bronchoscopy procedures. Additionally, it provides coated tubes and wires; and microelectromechanical systems sensor components. The company sells its products to hospitals and clinic-based physicians, technicians, and nurses through its direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was founded in 1987 and is headquartered in South Jordan, Utah.
Cap:
|
Volume (24h):